ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

ACD Honors Sullivan, Who Reaffirms Anti-Smoking Effort

June 29, 1990

Rogers Bill Would Authorize $937 Million For NCI In ‘78

March 4, 1977

ACS Funds $54 Million in Grants

June 28, 2002

In The States: Illinois, Virginia approve Legislation Mandating Coverage of Care In Cancer Clinical Trials

June 4, 1999

Healy Comes To Defense Of NCI’s Robert Wittes; Official Has Been Target Of Innuendo Over Taxo

September 11, 1992

Mayo Clinic Study Finds Samarium May Expand Options For Osteosarcoma

February 22, 2002